- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Stolz, L. E.
- Articles by York, J. D.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Stolz, L. E.
- Articles by York, J. D.
Identification and Characterization of an Essential Family of Inositol Polyphosphate 5-Phosphatases (INP51, INP52 and INP53 Gene Products) in the Yeast Saccharomyces cerevisiae
Leslie E. Stolza, Chau V. Huynhb, Jeremy Thornerb, and John D. Yorkaa Department of Pharmacology and Cancer Biology and Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710,
b Department of Molecular and Cell Biology, Division of Biochemistry and Molecular Biology, University of California, Berkeley, California 94720-3202
Corresponding author: John D. York, Department of Pharmacology and Cancer Biology, Duke University Medical Center, DUMC 3813, Durham, NC 27710, yorkj{at}acpub.duke.edu (E-mail).
Communicating editor: M. JOHNSTON
| ABSTRACT |
|---|
We recently demonstrated that the S. cerevisiae INP51 locus (YIL002c) encodes an inositol polyphosphate 5-phosphatase. Here we describe two related yeast loci, INP52 (YNL106c) and INP53 (YOR109w). Like Inp51p, the primary structures of Inp52p and Inp53p resemble the mammalian synaptic vesicle-associated protein, synaptojanin, and contain a carboxy-terminal catalytic domain and an amino-terminal SAC1-like segment. Inp51p (108 kD), Inp52p (136 kD) and Inp53p (124 kD) are membrane-associated. Single null mutants (inp51, inp52, or inp53) are viable. Both inp51 inp52 and inp52 inp53 double mutants display compromised cell growth, whereas an inp51 inp53 double mutant does not. An inp51 inp52 inp53 triple mutant is inviable on standard medium, but can grow weakly on media supplemented with an osmotic stabilizer (1 M sorbitol). An inp51 mutation, and to a lesser degree an inp52 mutation, confers cold-resistant growth in a strain background that cannot grow at temperatures below 15°. Analysis of inositol metabolites in vivo showed measurable accumulation of phosphatidylinositol 4,5-bisphosphate in the inp51 mutant. Electron microscopy revealed plasma membrane invaginations and cell wall thickening in double mutants and the triple mutant grown in sorbitol-containing medium. A fluorescent dye that detects endocytic and vacuolar membranes suggests that the vacuole is highly fragmented in inp51 inp52 double mutants. Our observations indicate that Inp51p, Inp52p, and Inp53p have distinct functions and that substrates and/or products of inositol polyphosphate 5-phosphatases may have roles in vesicle trafficking, membrane structure, and/or cell wall formation.
UPON agonist stimulation of mammalian cells, phospholipase C hydrolyzes phosphatidylinositol 4,5-bisphosphate (PtdIns[4,5]P2) to produce the second messengers, inositol 1,4,5-trisphosphate (Ins[1,4,5]P3) and diacylglycerol. Diacylglycerol activates protein kinase C, while Ins[1,4,5]P3 mobilizes intracellular Ca2+ (reviewed in ![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
A balance of kinase, phosphatase, and phospholipase activities regulates the cellular level of these soluble and lipid-linked inositol phosphates. These activities include the inositol polyphosphate 5-phosphatase (hereafter 5-Ptase) family (reviewed in ![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
The 5-Ptases are classified into four groups, based mainly on substrate specificity ( ![]()
![]()
![]()
![]()
![]()
![]()
![]()
Type II enzymes can hydrolyze both Ins[1,4,5]P3 and Ins[1,3,4,5]P4, as well as PtdIns[4,5]P2 and PtdIns[3,4,5]P3 ( ![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Type III 5-Ptases only hydrolyze PtdIns[3,4,5]P3 and are associated with PtdIns 3-kinase ( ![]()
![]()
![]()
![]()
It remains unclear why so many different 5-Ptases exist. However, the importance of these enzymes is demonstrated by examination of the S. cerevisiae genome sequence which revealed the presence of an open reading frame, which we designated INP51, that bears striking similarity to the synaptojanin subclass of 5-Ptases. Detailed characterization of INP51 is presented elsewhere (L. E. STOLZ, W. J. KUO, J. LONGCHAMPS, M. K. SEKHON, and J. D. YORK, unpublished results). With the completion of the entire S. cerevisiae genome, however, we found two additional open reading frames, designated INP52 and INP53, that are highly homologous to INP51. We demonstrate here that these two loci encode functional proteins of the predicted molecular weight. In addition, we describe the growth properties, biochemical consequences, and morphological perturbations that result from mutations in INP51, INP52, and INP53, alone and in combination. We show that these three genes comprise an essential gene family and provide additional insights about the potential cellular functions of these enzymes.
| MATERIALS AND METHODS |
|---|
Strains, media, and genetic methods:
Yeast strains used in this study are listed in Table 1. The cells were propagated in standard rich (YPD) medium, or in complete minimal medium (CM) lacking the appropriate nutrient(s) to maintain selection for plasmids or markers. Standard procedures for yeast genetic manipulations were used (![]()
![]()
|
Gene disruption and strain construction:
INP51 was disrupted and replaced with the LEU2 gene as described elsewhere (L. E. STOLZ, W. J. KUO, J. LONGCHAMPS, M. K. SEKHON, and J. D. YORK, unpublished results). The entire open reading frame of INP52 was disrupted and replaced with HIS3 as follows. HIS3 was amplified from pRS303 (![]()
) using the standard lithium acetate protocol (![]()
![]()
The entire INP53 open reading frame was also disrupted and replaced with the HIS3 gene as described above, except that the template providing HIS3 was plasmid pJJ217 ( ![]()
To construct inp51 inp52 and inp51 inp53 double mutants, haploid cells carrying the inp51::LEU2 allele were mated with cells of opposite mating type containing either the inp52::HIS3 allele or the inp53::HIS3 allele. The diploids were sporulated and dissected, then replica plated onto selective media to determine haploid double knockouts, which were verified one more time with PCR. To construct the inp52 inp53 double mutant, a haploid cell carrying the inp52::HIS3 allele was mated with a haploid cell of the opposite mating type carrying the inp53::HIS3 allele. The His+ spores were verified as double mutants by PCR.
To construct the inp51 inp52 inp53 triple mutant, a haploid inp51::LEU2 inp52::HIS3 double mutant was mated with a haploid inp53::HIS3 of the opposite mating type. Upon sporulation of the resulting diploid on normal medium, no nonparental ditype tetrads were found in which His+:His- segregrated 2:2 and cosegregated with Leu+, indicating that the triple mutation is lethal. To verify that the triple mutant is inviable, we introduced into the inp51::LEU2/INP51 inp52::HIS3/INP52 inp53::HIS3/INP53 diploid strain a plasmid, designated pRSINP51 (L. E. STOLZ, W. J. KUO, J. LONGCHAMPS, M. K. SEKHON, and J. D. YORK, unpublished results), which carries the wild-type INP51 gene driven by its endogenous promoter in the URA3-containing CEN vector, pRS316 (![]()
Immunoblot analysis:
Protein extracts were prepared from yeast strains by lysis of spheroplasts (![]()
Soluble and particulate fractions were diluted in 2x sodium dodecyl sulfate (SDS) gel sample buffer, resolved by electrophoresis on an 8% SDS polyacrylamide slab gel, and transferred electrophoretically to a nitrocellulose filter (Schleicher and Schuell, Inc., Keene, NH) using established procedures (![]()
![]()
Metabolic labeling and analysis of inositol-containing compounds:
Strains were inoculated at a density of 1 x 105 cells/ml in CM containing 20 µCi/ml of myo-[2-3H(N)]inositol (American Radiolabeled Chemicals, St. Louis, MO), grown to a density of 1 x 107 cells/ml, collected by centrifugation, and washed with ice-cold H2O. Cells were resuspended in 100 µl 0.5 N HCl, and, after the addition of 372 µl chloroform:methanol (1:2, v/v) and 100 µg acid-washed glass beads (Sigma Chemical Co., St. Louis), extracted by vigorous vortex mixing (bead beating) for 2 min. After addition of 125 µl each of chloroform and 2 M KCl, the mixture was subjected to vigorous vortex mixing for an additional 2 min. The resulting organic and aqueous phases were separated by centrifugation at 20,000 x g for 5 min. Inositol-containing lipids in the organic phase were resolved by thin layer chromatography on acid/oxalate-impregnated silica gel 60 thin layer plates as previously described (![]()
Electron microscopy:
Cells were fixed at 4° overnight with 2% glutaraldehyde in 150 mM Na-cacodylate (pH 7.2), washed with the same buffer lacking glutaraldehyde, postfixed on ice for 4 hr in the same buffer containing 2% osmium tetroxide, 1% potassium ferrocyanide, and 2.5 mM CaCl2, washed again in the cacodylate buffer lacking fixative, and finally washed with 200 mM Na-acetate (pH 5.2). Samples of the resulting cells were stained with 1% uranyl acetate in the acetate buffer overnight, washed and dehydrated, sequentially, by incubation (for 30 min each) in 30%, 60%, 80% and 95% ethanol, and, finally, three times in absolute ethanol. The dehydrated cells were impregnated for 1.25 hr in Spurr resin:ethanol (1:1), for 5 hr in two changes of undiluted Spurr resin, and embedded in fresh resin, which was polymerized at 70° for 8 hr. Sections (90 nm) were cut on a microtome (Reichert-Jung, Vienna, Austria), stained with uranyl acetate, followed by Sato lead, washed, and examined in an electron microscope (Philips EM300; Philips Technologies, Cheshire, CT).
Staining with FM 4-64:
Endocytic and vacuolar membranes were visualized by staining with the fluorescent vital dye FM 4-64 as described (![]()
| RESULTS |
|---|
A family of inositol polyphosphate 5-phosphatases in yeast:
We initially identified a yeast gene highly related to mammalian 5-Ptases by comparing the deduced amino acid sequences of three mammalian 5-Ptases, 5-Ptase I (Z31695), 5-Ptase II (M74161), and OCRL-1 (M88162) (with the indicated GenBank accession numbers), to the predicted open reading frames in the then available S. cerevisiae genomic sequence. This gene, which we designated INP51, resides on chromosome IX, corresponds to locus YIL002c, and encodes a predicted product of 946 residues which we characterized in detail, as described elsewhere (L. E. STOLZ, W. J. KUO, J. LONGCHAMPS, M. K. SEKHON, and J. D. YORK, unpublished results). With the completion of the S. cerevisiae genome sequence, we found two additional open reading frames highly homologous to INP51. The INP52 gene, locus YNL106c, lies on chromosome XIV and encodes a deduced product of 1183 residues. INP53, locus YOR109w, is situated on chromosome XV and encodes a predicted product of 1107 residues. If conservative amino acid substitutions are considered, Inp52p and Inp53p share ~70% similarity, whereas Inp51p is less related (30% similarity) to the other two INP5 gene products. Nonetheless, the presumptive C-terminal catalytic domains of all three gene products possess the signature motifs of demonstrated 5-Ptases (Figure 1). For example, identity to the consensus sequence, HDVIFWLGDLNYRI, is 71% for Inp51p and 85% for both Inp52p and Inp53p. Likewise, identity to a second highly conserved motif, PAWTDRILY is 100% for Inp51p and 77% for both Inp52p and Inp53p. In addition, the amino terminal halves of all three proteins share detectable similarity to the entire length of the 623-residue S. cerevisiae SAC1 gene product (Figure 1). Although SAC1 is not an essential gene, sac1
mutants are inositol auxotrophs and are cold-sensitive; moreover, particular sac1 alleles suppress certain act1ts alleles (![]()
mutation bypasses the effects of the sec14-1ts mutation (![]()
![]()
![]()
![]()
![]()
![]()
![]()
|
Additionally, we have identified a fourth putative 5-Ptase open reading frame in the S. cerevisiae genome which contains the two catalytic motifs described above. This open reading frame, which we designate INP54, corresponds to locus YOL065c on chromosome XV and encodes a predicted product of 384 residues. Significantly, Inp54p differs from the other three yeast 5-Ptases in that it lacks the Sac1p-like domain and based on its smaller size most resembles the mammalian Type I 5-Ptase (Figure 1).
Genetic analysis of INP51, INP52, and INP53 function:
To ascertain the roles that the INP51, INP52, and INP53 gene products play in the physiology of the yeast cell, we constructed mutant strains deficient in one or more of these proteins and examined their phenotype. A null mutation, inp51::LEU2, was constructed previously (L. E. STOLZ, W. J. KUO, J. LONGCHAMPS, M. K. SEKHON, and J. D. YORK, unpublished results). As described in MATERIALS AND METHODS, we also generated null mutations, inp52::HIS3 and inp53::HIS3, in the other two loci. Upon sporulation and tetrad dissection of each heterozygous diploid, four-spored tetrads were readily recovered in which the marker (either Leu+ or His+) segregated 2:2. Hence, inp51, inp52, and inp53 single mutants are all viable. The inp51::LEU2 and inp52::HIS3 spore clones appeared normal. In contrast, inp53::HIS3 spores yielded very small colonies compared to their sister His- (INP53+) spores. Upon restreaking, however, the inp53::HIS3 cells grew at a rate comparable to the wild-type cells (data not shown), suggesting that loss of Inp53p may cause a defect in germination.
To verify that INP51, INP52, and INP53 are expressed and to confirm that the null mutations prevented production of the corresponding polypeptides, we raised specific rabbit polyclonal antibodies directed against the Inp51p, Inp52p, and Inp53p proteins. Extracts of a wild-type haploid derived from the parental strain and of each single mutant were prepared and separated into soluble and particulate fractions. The proteins present were resolved by SDS-PAGE and examined by immunoblotting. In wild-type cells, each of the three proteins was found primarily in the particulate fraction and displayed an apparent molecular massInp51p (108 kD), Inp52p (133136 kD), and Inp53p (124125 kD)consistent with the molecular weight calculated from its deduced amino acid sequence (Figure 2). Since the extracts examined were prepared by lysis of thoroughly washed spheroplasts (see MATERIALS AND METHODS), this distribution suggests that all three proteins are membrane-associated. As expected, the inp51 mutant lacked the 108 kD species but retained the 133 and 125 kD species; likewise, the inp52 mutant only lacked the 133 kD protein (Figure 2A), and the inp53 mutant was only missing the 125 kD band (Figure 2B).
|
Since all three genes are expressed, the lack of overt phenotype of the three single mutants, and their homology to each other, suggested that the genes might be functionally redundant. To test this possibility, we used pairwise crosses and tetrad dissection (see MATERIALS AND METHODS) to isolate all three double mutant combinations. Like the single mutants, we found that inp51 inp52, inp51 inp53, and inp52 inp53 double mutant spores were obtained at the expected frequency, indicating that cells lacking two of the three gene products are still viable. However, the inp51 inp52 and the inp52 inp53 double mutant spores both grew distinctly slower than wild-type spore clones; the inp51 inp52 clones exhibited a greater degree of growth inhibition. These growth properties were reproducibly observed upon restreaking the double mutants onto growth media at 30° (Figure 3), and thus do not reflect effects on spore germination. In contrast, the inp51 inp53 double mutant germinated and grew at rates indistinguishable from wild-type cells (Figure 3).
|
We have noted previously that our parental strain (W303) grows poorly at temperatures below 15°, while the inp51 null mutation confers the ability to grow vigorously at such low temperatures ("cold tolerance") (L. E. STOLZ, W. J. KUO, J. LONGCHAMPS, M. K. SEKHON, and J. D. YORK, unpublished results). Therefore, we examined both the inp52 and inp53 single mutants, and the three double mutants, for their ability to grow at a variety of temperatures (12°, 18°, 23°, 30° and 37°) on rich medium. There were no growth differences between the single mutant cells and the wild type cells at 18°, 23°, 30° and 37° (data not shown). Unlike the inp51 mutation, neither the inp52 nor the inp53 mutation exhibited a dramatic improvement in growth at 12° (although the inp52 mutation had some modest effect) (Figure 3A). The inp51 inp53 and the inp52 inp53 double mutants showed at least as vigorous growth at 12° as the inp51 single mutant, whereas the inp51 inp52 cells grew no better than the inp52 single mutant (Figure 3A). To confirm that these growth effects were not simply due to differences in the number of viable cells applied to the plates, we dispersed individual cells using a micromanipulator and followed their growth under the microscope. At least five different cells were followed for each strain tested at 12° and 30°. We consistently observed, in agreement with the streak tests, that inp51 single mutants and inp51 inp53 and inp52 inp53 double mutants are able to grow at 12° (Figure 3B and Table 2). In addition, the inp52 single mutants and the inp51 inp52 double mutants demonstrate some mild cold tolerance, whereas the parental strain and the inp53 single mutants do not grow at 12°. Collectively, the growth phenotypes of the single mutants, and the genetic interactions observed in the double mutants, suggest that Inp51p, Inp52p, and Inp53p have some distinct roles in the cell, despite their sequence relatedness and presumed catalytic function.
|
Loss of Inp51p detectably increases the cellular pool of PtdIns[4,5]P2:
If Inp51p, Inp52p, and Inp53p serve as 5-Ptases in vivo, then the loss of these enzymes might lead to detectable perturbations in the cellular levels of PtdIns[4,5]P2 or Ins[1,4,5]P3 (or both). Such changes could provide some insight into the phenotypes of the mutants. Indeed, we report elsewhere that inp51 mutants do exhibit an increase in both the PtdIns[4,5]P2 and Ins[1,4,5]P3 pools as compared to wild-type cells (L. E. STOLZ, W. J. KUO, J. LONGCHAMPS, M. K. SEKHON, and J. D. YORK, unpublished results). It was of obvious interest to determine if the loss of Inp52p and Inp53p, alone or in combination with each other or Inp51p, might also have some effect. Cultures of the parental strain, the three single mutants, and the three double mutants were labeled with [3H]inositol to a steady-state. The incorporation of 3H into PtdInsP2 was analyzed by an oxalate-TLC method capable of resolving PtdIns, PtdInsP and PtdInsP2, as described in MATERIALS AND METHODS. In each of the strains carrying the inp51 null mutation (Table 3), the level of PtdInsP2 (presumably PtdIns[4,5]P2) was elevated two- to threefold as compared to the control cells, whereas the loss of either inp52 or inp53, or both, had no detectable effect. Moreover, neither the inp52 mutation nor the inp53 mutation, when combined with the inp51 mutation, caused any further increase in the accumulation of PtdInsP2 (above the inp51 single mutation). Likewise, examination of the inositol phosphates in the soluble fraction by HPLC, showed an increase in the levels of Ins[1,4,5]P3 in the inp51 cells as compared to the wild-type control; however, the inp52 and inp53 single mutants showed no detectable increase (data not shown). These results suggest that Inp51p is the major 5-Ptase in S. cerevisiae and/or that the bulk of the cellular pool of PtdIns- [4,5]P2 is accessible to Inp51p, but not to Inp52p or Inp53p. It is noteworthy that during revision of this manuscript ![]()
|
Evidence that INP51, INP52, and INP53 have an overlapping function:
Certain physiological functions in S. cerevisiae are carried out by related genes comprising an essential gene set. For example, there are three genes (TPK1, TPK2, and TPK3) that encode the catalytic subunit of cAMP-dependent protein kinase, and there are three genes that encode the G1 cyclins (CLN1, CLN2, and CLN3). To definitively establish whether INP51, INP52, and INP53 might constitute an essential gene set, we carried out appropriate genetic crosses (see MATERIALS AND METHODS) to generate a diploid strain heterozygous for all three null mutations. After sporulation and dissection, many of the tetrads segregated 3:1 for live:dead spores (Figure 4A) while the deduced triple mutant spores were always inviable (Figure 4A). To confirm that this segregation pattern was due exclusively to loss of the three gene products, the same heterozygous diploid was transformed with a URA3-marked CEN plasmid (pRS316) carrying the INP51 gene driven by its own promoter. As expected, upon sporulation and dissection of the plasmid-containing diploid, the majority of tetrads now segregated 4:0 for live:dead (Figure 4B). The deduced triple (Leu+ His+) mutant spores were viable (Figure 4C), and always Ura+. The plasmid-containing triple mutant strain was unable to grow on plates containing 5-FOA (Figure 4D), whereas control cells grew well on this medium (Figure 4E).
|
Examination of the presumptive inp51 inp52 inp53 spore clones under the microscope revealed that the cells proceed through four or five divisions before growth ceases when germinated on YPD medium (Figure 4F). However, when triple mutant spores were germinated on YPD plates supplemented with 1 M sorbitol and incubated at 23°, the cells were able to propagate continuously (Figure 4G), although at a rate much slower than that of wild-type cells.
Morphological effects of the loss of INP51, INP52, and INP53:
Because both lipid-linked and soluble inositol phosphates have been implicated in membrane trafficking and other processes that might affect cell morphology, we used electron microscopy to examine the effects of inp51, inp52, and inp53 mutations at the ultrastructural level. Cells were grown to midexponential phase at 30° and prepared for electron microscopy, as described in MATERIALS AND METHODS. Compared to the parental strain (W303), which had a large central vacuole and a smooth interface between the plasma membrane and the relatively thin (~200 nm) cell wall (Figure 5A), the inp51 and inp52 single mutants displayed no obvious differences (data not shown). In marked contrast, the inp53 single mutant and all three of the double mutants manifested, to different degrees, readily observable abnormalities, especially in the plasma membrane and the cell wall. In the inp53 mutant, and the inp51 inp53 double mutant, the wall (most prominently in the mother cell) is noticeably thicker (~300 nm), the plasma membrane appears to have increased in-pocketing, and the vacuole seems irregularly shaped (Figure 5B and Figure D). Gross morphological defects were found in the inp51 inp52 double mutant, wherein the plasma membrane displays enormous invaginations and convolutions, with corresponding abnormal depositions of cell wall material, and vesiculation of other cellular membranes (Figure 5C). These effects appear to be largely confined to mother cells, suggesting that this phenotype is the result of cumulative or age-related damage. In support of this hypothesis, we observed that, in exponentially growing cultures, only about 20% of the population displayed striking morphological defects, whereas 70% were mildly deformed, and 10% appeared relatively normal. Equally dramatic, the inp52 inp53 double mutant displayed clearly fragmented internal membranes and a pronounced thickening of the cell wall (
500 nm), which was detectable in both the mother and daughter cells (Figure 5E). Finally, we examined the inp51 inp52 inp53 triple mutant, which was propagated on medium containing 1 M sorbitol. These cells (both mother and bud) were clearly misshapen, containing markedly thickened (and even double-layered) cell walls, grossly distorted plasma membranes, and fragmentation of internal membranes (Figure 5F). The phenotype of the triple mutant suggests that loss of all three enzymes greatly exacerbates the effects of the absence of any individual enzyme.
|
Recently, ![]()
![]()
|
| DISCUSSION |
|---|
Mammalian cells possess at least ten distinct 5-Ptase isoforms (reviewed in ![]()
![]()
![]()
![]()
|
One possible model to explain these differential effects is that Inp51p acts in pathways or processes largely (but not completely) distinct from those involving Inp52p, and that Inp53p has a minor role (in terms of amount or activity) in both pathways, at least in vegetatively-growing cells. Inp54p has a completely distinct function in the cell. By this model, an inp51 single mutant survives because it can still carry out Inp52p-dependent events and, through Inp53p, can bypass the need for Inp51p. Likewise, an inp52 single mutant survives because it can carry out Inp51p-dependent events, and through Inp53p, can bypass the need for Inp52p. An inp53 single mutant survives because it can carry out both Inp51p- and Inp52p-dependent events. The fact that inp53 single mutants showed a mild germination defect and a mild morphological defect, especially in older mother cells, suggests that Inp53p may normally function primarily at stationary phase and/or under conditions of nutritional stress. Again, according to the proposed model, since the INP51 and INP52 gene products are postulated to have roles in two, largely separable, cellular pathways, combining null mutations in these two genes would be expected to yield the most severe phenotype, as was observed. In contrast, removal of INP53, since it is presumed to play a minor role in the INP51-dependent pathway would not be expected to markedly exacerbate the phenotype of an inp51 mutation; however, since Inp53p has some functional redundancy with Inp52p, removal of both INP52 and INP53 would completely block the INP52-dependent pathway, leading to a readily detectable growth phenotype, as we also found.
The fact that yeast can survive without all three enzymes, as long as osmotic support (1 M sorbitol) was provided in the medium, suggests that the major effect of the absence of these enzymes is a defect in membrane and/or cell wall structure and function, as was clearly confirmed by our ultrastructural analysis. However, sorbitol has been reported to have rather pleiotropic effects. In at least one strain background, 1 M sorbitol can rescue the lethality of a null mutation (stt4
) in a demonstrated PtdIns 4-kinase (![]()
![]()
![]()
![]()
![]()
![]()
![]()
Inp51p, Inp52p, and Inp53p are all expressed in exponentially-growing cells and seem to be associated largely with the particulate fraction, suggesting that each is membrane-associated. However, only inp51 mutations caused a detectable elevation in the total cellular pool of PtdIns[4,5]P2 and showed no further elevation when combined with either inp52 or inp53 mutations, suggesting that Inp51p is either responsible for the bulk of the PtdIns[4,5]P2-specific 5-Ptase activity in the cell or, alternatively, that it is localized to the cellular membranes that contain the highest PtdIns[4,5]P2 content. In this regard, it would be useful to determine the subcellular localization of these three enzymes. However, despite affinity-purification of the polyclonal antibodies, the expression level of each protein is too low to allow reliable detection by indirect immunofluorescence. Other approaches are in progress to address this important question, as well as related issues, such as the role, if any, of the potential CAAX box at the C terminus of Inp52p in its subcellular targeting. Another possibility to explain the inositol labeling results is that Inp51p is specific for PtdIns[4,5]P2 as a substrate, while Inp52p and Inp53p might act only on soluble inositol 5-phosphates. However, loss of Inp52p or Inp53p, or both, did not detectably elevate the cellular content of Ins[1,4,5]P3.
We have demonstrated elsewhere that the cold-tolerant phenotype of inp51 null strain correlates with the accumulation of PtdIns[4,5]P2 and does not require the production of soluble inositol phosphates (L. E. STOLZ, W. J. KUO, J. LONGCHAMPS, M. K. SEKHON, and J. D. YORK, unpublished results). Consistent with this observation, inp52 or inp53 null strains do not show measurable increases of PtdIns[4,5]P2 and do not exhibit cold-tolerant growth. Furthermore, the inp51 inp52 and the inp51 inp53 double mutants do not exhibit additive increases in either PtdIns[4,5]P2 or in growth rates at cold temperatures. A notable exception is the inp52 inp53 double mutant which is cold-tolerant despite the fact that increases in PtdIns[4,5]P2 were not detected. This leaves open the possibilities that either some other metabolite or changes in a minor pool of PtdIns[4,5]P2 (which are undetectable by our method) are sufficient for enabling the cold-tolerant growth. The mechanism by which cold resistance occurs is uncertain. We were unable to find reports of yeast deletion mutations that resulted in cold-tolerance; however, many mutations have been shown to result in cold-sensitivity. Mutations in the tryptophan biosynthetic pathway result in cold-sensitivity, presumably because the tryptophan permease cannot function at cold temperatures (![]()
Inp51p, Inp52p, and Inp53p are most closely related to mammalian synaptojanin both because of sequence relatedness and because synaptojanin and the three yeast proteins all contain an N-terminal domain homologous to Sac1p, which, in S. cerevisiae, is an integral membrane protein associated primarily with the Golgi compartment. Synaptojanin is colocalized to synaptic vesicles in presynaptic nerve terminals with the coated pit-associated GTPase, dynamin, and interacts with the SH2- and SH3-domains of Grb2 (![]()
![]()
![]()
![]()
![]()
![]()
![]()
The function of the Sac1p-like domain in synaptojanin and in Inp51p, Inp52p, and Inp53p is unclear. Null mutations in the SAC1 gene suppress Golgi transport defects and the inviability of a sec14ts mutation at the restrictive temperature (![]()
![]()
![]()
![]()
![]()
![]()
mutation, inp51
, inp52
, and inp53
mutations fail to "bypass" the Sec14p requirement, suggesting that despite the sequence similarity of the N-terminal domains of Inp51p, Inp52p, and Inp53p to Sac1p, these regions in the 5-Ptases may have a different function. We report elsewhere that deletion of the Sac1p-like domain (residues 2 to 490) of Inp51p results in a twofold increase in the level of PtdIns[4,5]P2 in vivo, consistent with the notion that this domain is required for proper cellular 5-Ptase function accumulation (L. E. STOLZ, W. J. KUO, J. LONGCHAMPS, M. K. SEKHON, and J. D. YORK, unpublished results). However, it is unclear whether the loss of function of the Sac1-less Inp51p is due to a loss of intrinsic activity or improper localization. In addition, a D426
A point mutation in the Sac1p-like domain of Inp51p does not result in lipid accumulation (L. E. STOLZ, W. J. KUO, J. LONGCHAMPS, M. K. SEKHON, and J. D. YORK, unpublished results). This is of interest because the mutations of the cognate D residue in Sac1p to N (indicated by the arrow in Figure 1) as found in the sac1-8 and sac1-22 alleles are able to create a "bypass" phenotype (![]()
There is considerable evidence that PtdIns[4,5]P2 modulates the activity of certain actin-binding proteins, such as profilin. It was conceivable, therefore, that loss of INP51, INP52, and/or INP53 might cause defects in the actin cytoskeleton. However, staining of inp51, inp52, and inp53 mutants, and all three double mutants, with rhodamine-phalloidin did not reveal any obvious abnormality in the distribution of filamentous actin in these cells (unpublished observations). In this same regard, another enzyme responsible for the removal of PtdIns[4,5]P2 is the Plc1p phospholipase (![]()
![]()
![]()
![]()
During preparation of this manuscript, it came to our attention that an independent study (![]()
Finally, during revision of this manuscript the existence of PtdIns[3,5]P2 in yeast was reported (![]()
| ACKNOWLEDGMENTS |
|---|
The authors thank JOHN MCMILLAN, DANIEL J. LEW, JOSEPH HEITMAN, JOHN J. MOSKOW, JEFFREY S. FLICK, BRYAN D. SPIEGELBERG, JOHN CONNOR and JASON LONGCHAMPS for technical advice and helpful discussions, and SARA MILLER and SUSAN HESTER for preparation of the electron micrographs. This work was supported by a Burroughs Wellcome Fund Career Development Award in the Biomedical Sciences, by funds from Merck Research Laboratories, by Research Grant HL-55672 from the National Heart, Lung, and Blood Institute (to J.D.Y.), by Predoctoral Traineeship GM07232 (to C.V.H.), and by Research Grant GM21841 from the National Institute of General Medical Sciences (to J.T.).
Manuscript received October 17, 1997; Accepted for publication December 16, 1997.
| LITERATURE CITED |
|---|
ATTREE, O., I. M. OLIVOS, I. OKABE, L. C. BAILEY, and D. L. NELSON et al., 1992 The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature 358:239-242[Medline].
AUSUBEL, F. M., R. BRENT, R. E. KINGSTON, D. D. MOORE, J. G. SEIDMAN et al. (Editors), 1995 Current Protocols in Molecular Biology, John Wiley & Sons, Inc., New York.
BANSAL, V. S. and P. W. MAJERUS, 1990 Phosphatidylinositol-derived precursors and signals. Ann. Rev. Cell Biol. 6:41-67.
BERRIDGE, M. J., 1993 Inositol trisphosphate and calcium signaling. Nature 361:315-325[Medline].
CHOWDHURY, S. K. W., M. C. SMITH AND, and M. C. SMITH ANDGUSTIN, 1992 Osmotic stress and the yeast cytoskeleton: phenotype-specific suppression of an actin mutation. J. Cell Biol. 118:561-571
CLEVES, A. E., P. J. NOVICK, and V. A. BANKAITIS, 1989 Mutations in the SAC1 gene suppress defects in yeast Golgi and yeast actin function. J. Cell Biol. 109:2939-2950
COMMUNI, D. and C. ERNEUX, 1996 Identification of an active site cysteine residue in human type I Ins(1,4,5)P3 5-phosphatase by chemical modification and site-directed mutagenesis. Biochem. J. 320:181-186.
COMMUNI, D., R. LECOCQ, and C. ERNEUX, 1996 Arginine 343 and 350 are two active site residues involved in substrate binding by human type I D-myo-inositol 1,4,5-trisphosphate 5-phosphatase. J. Biol. Chem. 271:11676-11683
CONNOLLY, T. M., T. E. BROSS, and P. W. MAJERUS, 1985 Isolation of a phosphomonoesterase from human platelets that specifically hydrolyzes the 5-phosphate of inositol 1,4,5-trisphosphate. J. Biol. Chem. 260:7868-7874
DAMEN, J. E., L. LIU, P. ROSTEN, R. K. HUMPHRIES, and A. B. JEFFERSON et al., 1996 The 145-kD protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase. Proc. Natl. Acad. Sci. USA 93:1689-1693
DE SMEDT, F., B. VERJANS, P. MAILLEUX, and C. ERNEUX, 1994 Cloning and expression of human brain type I inositol 1,4,5-trisphosphate 5-phosphatase. FEBS 347:69-72[Medline].
DE SMEDT, F., A. BLOOM, X. PESESSE, S. N. SCHIFFMAN, and C. ERNEUX, 1996 Post-translational modification of human brain type I inositol-1,4,5-trisphosphate 5-phosphatase by farnesylation. J. Biol. Chem. 271:10419-10424
DOVE, S. K., F. T. COOKE, M. R. DOUGLAS, L. G. SAYERS, and P. J. PARKER et al., 1997 Osmotic stress activates phosphatidylinositol-3,5-bisphosphate synthesis. Nature 390:187-192[Medline].
DRAYER, A. L., X. PESESSE, F. DE SMEDT, D. COMMUNI, and C. MOREAU et al., 1996 The family of inositol and phosphatidylinositol polyphosphate 5-phosphatases. Biochem. Soc. Trans. 24:1001-1005[Medline].
FLANAGAN, C. A., E. A. SCHNIEDERS, A. W. EMERICK, R. KUNISAWA, and A. ADMON et al., 1993 Phosphatidylinositol 4-kinase: gene structure and requirement for yeast cell viability. Science 262:1444-1448
FLICK, J. S. and J. THORNER, 1993 Genetic and biochemical characterization of a phosphatidylinositol-specific phospholipase C in Saccharomyces cerevisiae. Mol. Cell. Biol. 13:5861-5876
GUTHRIE, C., and G. R. FINK (Editors), 1991 Guide to Yeast Genetics and Molecular Biology. Academic Press, Inc., New York.
HARLAN, J. E., P. J. HAJDUK, H. S. YOON, and S. W. FESIK, 1994 Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate. Nature 371:168-170[Medline].
HARLOW, E., and W. LANE, 1988 Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
HARTWIG, J. H., G. M. BOKOCH, C. L. CARPENTER, P. A. JANMEY, and L. A. TAYLOR et al., 1995 Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets. Cell 82:643-653[Medline].





